Industry Commitment For Antibiotic Resistance Strategy

by | Apr 8, 2014 | News | 0 comments

In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.

Recent GVL Blog Posts

Indiana Accepts Extended Equine Certificate of Veterinary Inspection

Indiana Accepts Extended Equine Certificate of Veterinary Inspection

Six-month horse health certificate program now includes IndianaEquine owners in Indiana have a new paperless option for interstate travel with their horses, as the state now accepts Extended Equine Certificates of Veterinary Inspection (EECVI). By allowing the use of...

Join us at this year’s AASV Annual (Virtual) Meeting

Join us at this year’s AASV Annual (Virtual) Meeting

The GVL team is looking forward to the annual AASV Annual Meeting, a virtual conference. Don't miss these Industrial Partners Presentations.AASV Annual MeetingGVL - Tech Table ExhibitFebruary 27-March 2, 2021Virtual Learn more: aasv.orgSoftware Integrations provide...